This is the world’s first Covid=19 DNA vaccine developed in partnership with DBT-BIRAC
ZyCoV-D had already exhibited a robust immunogenicity and tolerability and safety profile in the adaptive Phase I/II clinical trials
Subscribe To Our Newsletter & Stay Updated